JERRY LEVENTHAL: Open Payments
NPI 1558364265 · PALM COAST, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$941 in 42 payments from 13 companies in 2025. Trend: 2023 $1,131 · 2024 $911 · 2025 $941
Food & beverage: $941
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $280 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $112 |
| Lilly USA, LLC | 5 | $108 |
| Exact Sciences Corporation | 5 | $104 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $72 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| ACADIA Pharmaceuticals Inc | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| ALK-Abello, Inc | 1 | $32 |
| HARTMANN USA, INC. | 1 | $24 |
Products named: Ozempic, JARDIANCE, The Cologuard Plus Collection Kit, Wegovy, Kerendia, DAYBUE, BREZTRI, CAPLYTA.
Industry payments across FL — which companies pay providers there.
